Intercept Pharmaceuticals logo
Intercept Pharmaceuticals ICPT
€ 18.31 0.0%

Quartalsbericht 2023-Q3
hinzugefügt 06.11.2023

report update icon

Intercept Pharmaceuticals Kennzahlen 2011-2024 | ICPT

Kennzahlen Jährlich Intercept Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-33.9 -14.3 -3.0 -8.5 -10.7 -4.7 -6.3 -11.1 -14.8 -79.4 -5.7 -

P/S

9.1 7.6 3.5 11.6 18.4 12.8 104.6 904.7 2399.1 3318.6 101.9 -

EPS

-0.5 -1.2 -8.3 -10.9 -10.9 -14.4 -16.7 -9.6 -13.6 -3.8 -7.4 -4.7

EV (Enterprise Value)

1.12 B 1.15 B 1.5 B 3.55 B 3.75 B 2.08 B 2.99 B 2.54 B 4.18 B 5.44 B 250 M 4.32 M

EBITDA per Share

-0.54 -0.83 -6.88 -9.75 -9.87 -13.2 -16.2 -9.6 -5.42 -2.18 -2.98 -

EV/EBITDA

-21.6 -7.6 -11.0 -12.9 -5.9 -7.3 -10.9 -36.9 -136.4 -10.9 -

PEG

0.95 0.44 2.55 -30.68 0.44 0.33 -0.08 0.37 -0.06 1.62 -0.01 -

P/B

7.6 -2.8 -4.9 56.7 172.8 102.6 8.3 4.2 18.1 65.3 3.8 -

P/CF

-26.4 -12.7 -4.7 -12.3 -13.7 -6.1 -7.5 -14.9 -45.2 -181.6 -15.8 -

ROE %

-22.37 19.72 164.74 -668.56 -1616.53 -2199.24 -131.09 -37.60 -122.67 -82.27 -66.21 -

ROA %

-3.76 -6.88 -47.35 -45.66 -60.73 -74.40 -55.84 -34.53 -111.44 -45.10 -38.90 -

ROCE %

-20.32 15.86 137.68 -52.70 -72.28 -88.25 -60.92 -37.67 -47.37 -27.89 -19.06 -

Current Ratio

1.2 0.7 0.8 4.5 4.2 4.3 9.0 13.5 16.1 16.6 8.6 -

DSO

130.5 185.8 62.1 55.1 52.2 51.8 180.4 484.3 535.9 310.2 80.2 -

DIO

2660.5 2561.1 1356.5 - - - - - - - - -

DPO

5903.8 6390.1 3379.2 1644.3 1704.7 1854.3 - - - - - -

Betriebszyklus

2791.0 2746.9 1418.5 55.1 52.2 51.8 - - - - - -

Finanzkreislauf

-3112.8 -3643.2 -1960.7 -1589.2 -1652.6 -1802.5 - - - - - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Intercept Pharmaceuticals

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.07 -0.14 -0.77 - 7.8 -0.25 -0.58 - -0.11 -0.33 -1.22 -1.58 -2.01 -1.92 -2.86 -2.99 -2.59 -2.28 -3.03 -2.97 -2.18 -2.58 -3.22 -4.43 -2.89 -3.46 -3.61 -4.84 -3.59 -3.14 -5.17 -3.62 -2.1 -1.99 -1.78 -1.63 -1.69 1.6 -12.61 -0.64 -1.65 -0.79 -0.62 -2.02 -1.86 -1.75 -1.03 -1.32 -1.08 -1.1 -1.23

EBITDA per Share

- - -0.76 - -0.28 -0.45 -0.88 - -0.54 0.02 -0.86 -1.23 -1.6 -1.53 -2.54 -2.72 -2.22 -1.97 -2.79 -2.76 -1.85 -2.31 -2.93 -4.17 -2.51 -3.14 -3.34 -4.59 -3.27 -3.11 -5.17 -3.64 -2.09 -2.01 -1.78 - 0.01 0.01 - - - - - - 0.05 0.02 0.02 - 0.05 - -

ROE %

187.99 440.26 450.98 255.07 257.40 11.34 14.76 28.00 59.25 96.76 129.23 164.74 -56.90 -261.28 -437.74 -668.56 -938.20 -1110.58 -1365.12 -1616.53 -1835.56 -1941.70 -2076.92 -2199.24 -1558.29 -1143.42 -639.68 -131.09 -107.62 -87.88 -71.29 -37.60 -38.03 -45.10 -22.65 -122.67 -122.59 -145.58 -176.43 -82.27 -113.82 -83.18 -74.54 -66.21 122.78 241.63 249.34 142.43 110.98 - -

ROA %

39.52 88.04 85.81 40.94 40.25 -4.82 -6.94 -10.59 -19.57 -30.33 -39.11 -47.35 -51.37 -51.16 -49.72 -45.66 -49.94 -51.36 -56.67 -60.73 -66.42 -68.76 -71.86 -74.40 -67.67 -64.69 -57.28 -55.84 -53.06 -48.81 -45.66 -34.53 -34.77 -41.12 -20.64 -111.44 -105.97 -112.98 -135.11 -45.10 -64.23 -47.74 -43.31 -38.90 -30.27 -40.24 -35.70 -18.72 -14.59 - -

ROCE %

-73.47 -76.46 -62.31 1.30 13.84 35.80 31.82 26.84 51.17 71.69 103.25 138.59 -58.94 -238.50 -393.16 -606.00 -861.30 -1019.48 -1260.75 -1492.37 -1704.48 -1803.62 -1930.19 -2048.16 -1443.76 -1066.30 -599.77 -127.82 -106.38 -88.61 -71.92 -38.06 -23.29 -14.69 -6.59 - - - - - - - - - - - - - - - -

Current Ratio

1.2 1.2 1.1 1.2 1.2 - 0.6 0.7 0.8 0.7 0.7 0.8 0.8 0.8 0.8 1.1 1.1 1.1 1.1 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.7 1.7 1.7 1.7 12.2 12.2 12.2 12.2 10.9 10.9 10.9 10.9 2.2 2.2 2.2 2.2 2.4 2.4 2.4 2.4 0.9 0.9 - -

DSO

32.0 31.9 37.3 - 15.4 29.3 57.5 - 62.6 41.5 47.0 45.5 47.7 49.1 50.0 48.5 56.0 52.4 55.6 44.0 49.9 53.8 53.5 40.0 36.4 48.8 55.5 60.3 160.9 150.9 940.5 4.8 - - 34.4 - - - - - - - - - - - - - - - -

DIO

2066.1 3140.2 2655.9 - 675.1 1219.2 3302.2 - 3622.3 1328.6 1015.0 - 451.1 438.9 936.5 - 1585.5 1140.6 1237.6 - 1135.9 826.8 1725.3 - 1846.2 1138.2 2708.8 - - - - - - - - - - - - - - - - - - - - - - - -

DPO

2397.5 3163.9 5544.5 - 2292.3 1533.5 5725.4 - 6110.5 2043.2 2094.1 - 1229.0 1195.6 2333.1 - 3555.4 2557.6 2443.4 - 2068.5 1505.7 3052.0 - 3695.1 2278.0 6437.8 - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

2098.1 3172.1 2693.2 - 690.5 1248.5 3359.6 - 3684.9 1370.1 1062.0 45.5 498.8 487.9 986.5 48.5 1641.6 1192.9 1293.2 44.0 1185.8 880.6 1778.8 40.0 1882.7 1186.9 2764.4 60.3 160.9 150.9 940.5 4.8 - - 34.4 - - - - - - - - - - - - - - - -

Finanzkreislauf

-299.4 8.2 -2851.2 - -1601.8 -285.0 -2365.8 - -2425.6 -673.1 -1032.1 45.5 -730.2 -707.7 -1346.6 48.5 -1913.8 -1364.6 -1150.2 44.0 -882.7 -625.1 -1273.2 40.0 -1812.4 -1091.1 -3673.5 60.3 160.9 150.9 940.5 4.8 - - 34.4 - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung